Anvisa has granted Eurofarma the first generic registration for the dapagliflozin-metformin fixed-dose combination, mandating a minimum 35% price discount versus AstraZeneca’s Xigduo XR under Generic Law 9.787/1999.
Anvisa has granted Eurofarma the first generic registration for the dapagliflozin-metformin fixed-dose combination, mandating a minimum 35% price discount versus AstraZeneca’s Xigduo XR under Generic Law 9.787/1999.
You must be logged in to post a comment.